Hypomagnesemia and Mitral Valve Prolapse in Cavalier King Charles Spaniels

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 45, Issue 10, 1998, Pages 607-614

  Pedersen, H D ^a   Mow, T ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

EID: 2542574199     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0442.1998.tb00865.x     Document Type: Article

References (36)

1. BEARDOW, A. W., and J, W. BUCHANAN, 1993: Chronic mitral valve disease in Cavalier King Charles Spaniels: 95 cases (1987-1991). J. Am. Vet. Med. Assoc. 203, 1023-1029.
2. BOUDOULAS, H., and C. F. WOOLEY, 1988: Hyperadrenergic state, autonomic dysfunction, and pathogenesis of symptoms in mitral valve prolapse syndrome. In: H. BOUDOULAS and C. F. WOOLEY (eds) Mitral valve prolapse and the mitral valve prolapse syndrome. Futura Publishing Company Inc, Mount Kisco, NY, USA, pp. 479-510.
3. COBB, M., and A. R. MICHELL, 1992: Plasma electrolyte concentrations in dogs receiving diuretic therapy for cardiac failure. J. Small Anim. Pract. 33, 526-529.
4. COGHLAN, H. C., and G. NATELLO, 1992: Erythrocyte magnesium in symptomatic patients with primary mitral valve prolapse: relationship to symptoms, mitral leaflet thickness, joint hypermobility and autonomic regulation. Magnes. Trace Elem. 10, 205-214.
5. COHEN, L., H. BITTERMAN, E. GRENADIER, A. LAOR, N. LAHAT, and A. PALANT, 1986: Idiopathic magnesium deficiency in mitral valve prolapse. Am. J. Cardiol. 57, 486-487.
6. DARKE, P. G. G., 1987: Valvular incompetence in Cavalier King Charles Spaniels. Vet. Rec. 120, 365-366.
7. DHUPA, N., and J. PROULX, 1998: Hypocalcemia and hypomagnesemia, Vet. Clin. North Am. Small Anim. Pract. 28, 587-608.
8. DURLACH, J., 1994: Primary mitral valve prolapse: a clinical form of primary magnesium deficit. Magnes. Res. 7, 339-340.
9. DURLACH, J., P. BAC, V. DURLACH, M. BARA, and A. GUIET-BARA, 1997: Neurotic, neuromuscular and autonomic nervous form of magnesium imbalance. Magnes. Res. 10, 169-195.
10. DUX, S., J. ROSENFELD, A. YARON, and A. CARMEL, 1981: More on captropril and measurement of angiotensin-converting enzyme. N. Engl. J. Med. 304, 423-424.
11. ELIN, R. J., 1987: Overview of problems in the assessment of magnesium status. In: B. M. ALTURA, J. DURLACH, and M. S. SEELIG (eds) Magnesium in cellular processes and medicine. Karger, Basel, pp. 67-76.
12. ELIN, R J., 1988: Magnesium metabolism in health and disease. Dis. Mon. 34, 161-218.
13. GALLAND, L. D., S. M. BAKER, and R. K. McLELLAN, 1986: Magnesium deficiency in the pathogenesis of mitral valve prolapse. Magnesium 5, 165-174.
14. GOMPF, R. E., 1988: The clinical approach to heart disease: history and physical examination. In: P. R. FOX (ed.) Canine and feline cardiology. Churchill Livingstone, New York, NY, USA, pp. 29-42.
15. HAGGSTROM, J., K. HANSSON, C. KVART, and L. SWENSON, 1992: Chronic valvular disease in the Cavalier King Charles Spaniel in Sweden. Vet. Rec. 131, 549-553.
16. JENSEN, A. L., and J. KOCH, 1992: Determination of angiotensin converting enzyme in canine serum. Clin. Chem. Enzym. Comms. 4, 311-317.
17. KELLY, N. C., and J. M. WILLS (eds), 1996: Manual of companion animal nutrition & feeding. British Small Animal Veterinary Association, Cheltenham, UK, p. 254.
18. KAHNNA, C., E. M. LUND, M. RAFFE, and P. J. ARMSTRONG, 1998: Hypomagnesemia in 188 dogs: A hospital population-based prevalence study. J. Vet. Intern. Med. 12, 304-309.
19. LEWIS, L. D., M. L. MORRIS, and M. S. HAND, 1987: Small animal clinical nutrition III. Mark Morris Associates, Topeka, KS, USA.
20. LICHODZIEJEWSKA, B., J. KŁOŚ, J. REZLER, K. GRUDZKA, M. DŁUZNIEWSKA, A. BUDAJ, and L. CEREMUŻYŃSKI, 1997: Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. Am. J. Cardiol. 79, 768-772.
21. LUMSDEN, J. H., K. MULLEN, and B. J. MCSHERRY, 1979: Canine hematology and biochemistry reference values. Can. J. Comp. Med. 43, 125-131.
22. NAKAYAMA, T., Y. WAKAO, H. NEMOTO, M. UECHI, T. KAGEYAMA, M. MUTO, and T. TAKAHASHI, 1996: Mitral valve protrusion assessed by use of B-mode echocardiography in dogs with mitral regurgitation. Am. J. Vet. Res. 57, 791-797.
23. PESERSEN, H. D., B. Ø. KRISTENSEN, K. A. LORENTZEN, J. KOCH, A. L. JENSEN, and A. FLAGSTAD, 1995a: Mitral valve prolapse in 3-year-old healthy Cavalier King Charles Spaniels. An echocardiographic study. Can. J. Vet. Res. 59, 294-298.
24. PEDERSEN, H. D., L. H. OLSEN, and H. ARNORSDOTTIR, 1995b: Breed differences in the plasma renin activity and plasma aldosterone concentration of dogs. J. Vet. Med. A. 42, 435-441.
25. PEDERSEN, H. D., J. KOCH, K. POULSEN, A. L. JENSEN, and A. FLAGSTAD, 1995c: Activation of the renin-angiotensin system in dogs with asymptomatic and mildly symptomatic mitral valvular insufficiency. J. Vet. Intern. Med. 9, 328-331.
26. PEDERSEN, H. D., 1996: Effects of mild mitral valve insufficiency, sodium intake, and place of blood sampling on the renin-angiotensin system in dogs. Acta Vet. Scand. 37, 109-118.
27. PEDERSEN, H. D., B. Ø. KRISTENSEN, B. NØRBY, and K. A. LORENTZEN, 1996a: Echocardiographic study of mitral valve prolapse in Dachshunds. J. Vet. Med. A. 43, 103-110.
28. PEDERSEN, H. D., K. A. LORENTZEN, and B. Ø. KRISTENSEN, 1996b: Observer variation in the two-dimensional echocardiographic evaluation of mitral valve prolapse in dogs. Vet. Radiol. Ultrasound 37, 367-372.
29. PEDERSEN, H. D., K. A. LORENTZEN, and B. Ø. KRISTENSEN, 1998a: Echocardiographic mitral valve prolapse in Cavalier King Charles Spaniels: Epidemiology and prognostic significance for regurgitation. Vet. Rec. (in press).
30. PEDERSEN, H. D., L. H. OLSEN, T. MOW, and N. J. CHRISTENSEN, 1998b: Neuroendocrine changes in Dachshunds with mitral valve prolapse examined in different study conditions. Res. Vet. Sci. (in press).
31. PIETILA, K., and T. KOIVULA, 1984: Increase of serum angiotensin-converting enzyme activity after freezing. Scand. J. Clin. Lab. Invest. 44, 453-455.
32. POULSEN, K., and J. JØRGENSEN, 1974: An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody. J. Clin. Endocrinol. Metab. 39, 816-825.
33. RALSTON, M. A., M. R. MURNANE, R. E. KELLEY, R. A. ALTSCHULD, D. V. UNVERFERTH, and C. V. LEIER, 1989: Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure. Circulation 80, 573-580.
34. REINHART, R. A., 1988: Magnesium metabolism. A review with special reference to the relationship between intracellular content and serum levels. Arch. Intern. Med. 148, 2415-2420.
35. SIMÕES FERNANDES J., T. PEREIRA, J. CARVALHO, A. FRANCA, R. ANDRADE, J. NOGUEIRA PEREIRA, J. C. RODRIGUES, M. J. LAIRES, and M. J. HALPERN, 1985: Therapeutic effect of magnesium salt in patients suffering from mitral valvular prolapse and latent tetany. Magnesium 4, 283-290.
36. ZDROJEWSKI, T. R., B. WYRZYKOWSKI, and B. KRUPA-WOJCIECHOWSKA, 1995: Renin-aldosterone regulation during upright posture in young men with mitral valve prolapse syndrome. J. Heart Valve Dis. 4, 236-241.